Education
About Us
Working with TipRanks
Follow Us
Azitra Inc (AZTR)
:AZTR
Atr12-351
Netherton Syndrome
Phase I
Recruiting
Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome
Nov 07, 2023
―
Atr-04
Papulopustular Rosacea, Epidermal Growth Factor
Phase I/II
Suspended
Study to Evaluate the Safety of ATR-04
Jan 14, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Azitra Inc (AZTR) have in its pipeline
AZTR is currently developing the following drugs: Atr12-351, Atr-04, Atr04-484, Vehicle. These drug candidates are in various stages of clinical development as the company works toward FDA approval.